TU-100

DRUG4 trials

Sponsors

Tsumura USA

Conditions

Crohn's DiseaseDelay in GI Recovery/Postoperative Ileus (POI)Enhanced Recovery After SurgeryIrritable Bowel Syndrome in Females

Phase 2

A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease

TerminatedNCT01388933

Tsumura USACrohn's Disease

Start: 2011-09-30End: 2013-09-30Updated: 2015-06-11

A Safety and Efficacy Study of Daikenchuto (TU-100) to Relieve Abdominal Bloating in Female Subjects With Irritable Bowel Syndrome

CompletedNCT02074579

Tsumura USAIrritable Bowel Syndrome in Females

Start: 2014-07-31End: 2016-04-30Updated: 2017-05-02

Safety and Efficacy of TU-100 as an Adjunct to an Enhanced Recovery After Surgery in Subjects Undergoing Bowel Resection

CompletedNCT04742907

Tsumura USAEnhanced Recovery After Surgery

Start: 2021-07-29End: 2024-05-01Updated: 2025-04-16

TU-100 for Accelerating GI Recovery After Major Abdominopelvic Surgery (RC & CAWR)

Not yet recruitingNCT07765589

Tsumura USADelay in GI Recovery/Postoperative Ileus (POI)

Start: 2026-12-01End: 2028-07-01Target: 240Updated: 2026-08-14

Related Papers

Evaluation of TU-100 (Daikenchuto), a Traditional Japanese Kampo Medicine, as an Adjunct to Enhanced Recovery After Surgery, for Acceleration of Gastrointestinal Recovery After Bowel Resection: Results of a Proof-of-Concept, Phase 2, Randomized, Double-Blinded, Placebo-Controlled Trial.

2025-10-20